We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Publication, Part of Prescribing Costs in Hospitals and the Community
Hospital Prescribing - England, 2013/14
Official statistics- Publication Date:
- 12 Nov 2014
- Geographic Coverage:
- England
- Geographical Granularity:
- Regions, Country, Strategic Health Authorities
- Date Range:
- 01 Apr 2013 to 31 Mar 2014
Summary
This report compares expenditure between primary and secondary care in total and for medicines positively appraised by NICE.
On 14 November 2014, an additional Excel file was made available, containing the underlying data from all the Tables and Figures in the report.
Highlights
The overall NHS expenditure on medicines in 2013-14 was £14.4 billion.
In 2013-14 hospital use accounted for 40.1 per cent of the total cost, up from 37.5 per cent in 2012-13.
The cost of medicines rose by 7.6 per cent overall but by 15.1 per cent in hospitals, from 2012-13 to 2013-14.
Of the drugs positively appraised by NICE, the greatest overall cost in 2013-14 was for Adalimumab, which also incurred the greatest cost in hospitals.
Resources
Last edited: 27 June 2018 9:37 am